Leadless Cardiac Pacemaker Market Growth, Trends, Size, Scope, Revenue and Future Outlook

Leadless Cardiac Pacemaker Market Size- By Type, By Technology, By Condition, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Leadless Cardiac Pacemaker Market Size- By Type, By Technology, By Condition, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Feb 2018 Report ID: HLCA1805 Pages: 1 - 108 Formats*:     
Category : Healthcare
Leadless Cardiac Pacemaker Market Introduction and Overview 

According to SPER Market Research, the Global Leadless Cardiac Pacemaker Market is estimated to reach USD 0.60 billion by 2033 with a CAGR of 17.42%.

The report includes an in-depth analysis of the Global Leadless Cardiac Pacemaker Market, including market size and trends, product mix, distribution channels, and supplier analysis. The leadless pacing system is an innovative technology found in the market for cardiac pacemakers. These devices are smaller than traditional pacemakers and do not require leads, which helps eliminate potential complications related to leads and the pacemaker pocket. However, their usage is currently limited to single-chamber ventricular pacing, specifically in cases of permanent sinus node dysfunction, atrial fibrillation, and atrioventricular block.

  • February 2022: Abbott recently introduced a dual-chamber leadless pacemaker device as a part of the AVEIR DR i2i pivotal clinical trial. This unveiling represents a notable advancement in leadless pacing technology, with the first patient in the pivotal study being implanted with Abbott's investigational Aveir dual-chamber leadless pacemaker. This milestone showcases the significant progress achieved in the field of leadless pacing technology.
  • January 2022: Medtronic plc has received regulatory approval from Japan's Ministry of Health, Labor, and Welfare to sell and have the Micra AV Transcatheter Pacing System (TPS) reimbursed. The company intends to launch this product in the market in June 2022.
Leadless Cardiac Pacemaker Market
Market Opportunities and Challenges
The market for leadless cardiac pacemakers offers a variety of opportunities as well as a number of challenges. The global increase in the prevalence of cardiac diseases, which has spurred the desire for cutting-edge, minimally invasive pacing devices, presents one big potential. Lead-free cardiac pacemakers differ from conventional pacemakers in a number of ways, including size, the absence of lead-related problems, and a reduced need for surgical intervention. These elements help the market grow and adoption rates increase. Leadless cardiac pacemakers are anticipated to function better and have more features in the future thanks to technical developments and continuous R&D projects, which will boost the market's expansion. In order to better serve patients with a wider spectrum of cardiac diseases, researchers are concentrating on creating multi-chamber leadless pacing systems and increasing battery life. 

The leadless cardiac pacemaker market, however, also confronts difficulties. One significant obstacle is the expensive price tag attached to these cutting-edge technologies, which restricts their accessibility in some areas and for individuals with low financial resources. Additionally, different countries' regulatory and reimbursement difficulties may limit market expansion. Leadless pacemakers are also still not widely used in more complicated situations like dual-chamber pacing, even if they are appropriate for some indications like single-chamber ventricular pacing. Manufacturers still face a considerable challenge in overcoming technological obstacles and broadening the application of leadless pacing systems to treat a wider spectrum of cardiac diseases.

Leadless Cardiac Pacemaker Market


Market Competitive Landscape
The leadless cardiac pacemaker market demonstrates consolidation, primarily attributed to the presence of a small number of global and regional companies. The competitive landscape encompasses the analysis of both international and local companies that hold substantial market shares. Key players in the market include Abbott Laboratories Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Edward Lifesciences Corporation, Lepu Medical Technology, MEDICO S.p.A., Medtronic Plc, SORIN S.p.A, Terumo Corporation, Vitatron, others. These companies are widely recognized for their contributions and advancements in the field of leadless cardiac pacemakers.

Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2033
 Base year considered 2022
 Forecast period 2023-2033
 Segments coveredBy Type, By Technology, By Condition, By End User
 Regions coveredAsia-Pacific, Europe, Middle East and Africa, North America, Latin America, Others
 Companies CoveredAbbott Laboratories Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Edward Lifesciences Corporation, Lepu Medical Technology, MEDICO S.p.A., Medtronic Plc, SORIN S.p.A, Terumo Corporation, Vitatron, others
COVID-19 Impact on Global Leadless Cardiac Pacemaker Market
The COVID-19 epidemic has had a substantial influence on the global leadless cardiac pacemaker business. Elective treatments have been delayed and the number of patients visiting hospitals and clinics has decreased as a result of the outbreak. The use of leadless cardiac pacemakers has been negatively impacted by these factors. Players in the market have faced difficulties as a result of manufacturing constraints and supply chain interruptions. The market is anticipated to pick up steam, though, as healthcare systems gradually recover and vaccination rates rise. In the post-pandemic period, market growth is probably driven by the rising knowledge of the advantages given by leadless pacemakers, such as less infection risk and enhanced patient comfort.

Key Target Audience
  • Cardiologists 
  • Electrophysiologists
  • Heart Rhythm Specialists
  • Medical Device Industry Professionals
  • Patients with Bradycardia
  • Others
Our in-depth analysis of the Leadless Cardiac Pacemaker Market includes the following segments:
By Type:
  • Micra Transcatheter Pacing Systems
  • Nanostim Leadless Cardiac Pacemakers
  • Wireless Cardiac Simulation Systems
  • By Technology:
  • Dual Chamber Pacemaker
  • Single Chamber Pacemaker
  • By Condition:
  • Atrial fibrillation
  • Atrioventricular Block
  • Sinus Node Dysfunction
  • By End User:
  • Academic & Research Institutes
  • Ambulatory Surgical Centers
  • Hospitals
  • Others
  • Key Topics Covered in the Report
    • Global Leadless Cardiac Pacemaker Market Size (FY’2023-FY’2033)
    • Overview of Global Leadless Cardiac Pacemaker Market
    • Segmentation of Global Leadless Cardiac Pacemaker Market By Type (Micra Transcatheter Pacing Systems, Nanostim Leadless Cardiac Pacemakers, Wireless Cardiac Simulation Systems)
    • Segmentation of Global Leadless Cardiac Pacemaker Market By Technology (Dual Chamber Pacemaker, Single Chamber Pacemaker)
    • Segmentation of Global Leadless Cardiac Pacemaker Market By Condition (Atrial fibrillation, Atrioventricular Block, Sinus Node Dysfunction)
    • Segmentation of Global Leadless Cardiac Pacemaker Market By End User (Academic & Research Institutes, Ambulatory Surgical Centers, Hospitals, Others)
    • Statistical Snap of Global Leadless Cardiac Pacemaker Market
    • Expansion Analysis of Global Leadless Cardiac Pacemaker Market
    • Problems and Obstacles in Global Leadless Cardiac Pacemaker Market
    • Competitive Landscape in the Global Leadless Cardiac Pacemaker Market
    • Impact of COVID-19 and Demonetization on Global Leadless Cardiac Pacemaker Market
    • Details on Current Investment in Global Leadless Cardiac Pacemaker Market
    • Competitive Analysis of Global Leadless Cardiac Pacemaker Market
    • Prominent Market Players in the Global Leadless Cardiac Pacemaker Market
    • SWOT Analysis of Global Leadless Cardiac Pacemaker Market
    • Global Leadless Cardiac Pacemaker Market Future Outlook and Projections (FY’2023-FY’2033)
    • Recommendations from Analyst
    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Global Leadless Cardiac Pacemaker Market

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Global Leadless Cardiac Pacemaker Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Leadless Cardiac Pacemaker Market

    7. Global Leadless Cardiac Pacemaker Market, By Type (USD Million)
    7.1. Global Leadless Cardiac Pacemaker Market Value Share and Forecast, By Type, 2023-2033 
    7.2. Micra Transcatheter Pacing Systems
    7.3. Nanostim Leadless Cardiac Pacemakers
    7.4. Wireless Cardiac Simulation Systems

    8. Global Leadless Cardiac Pacemaker Market, By Technology (USD Million)
    8.1. Global Leadless Cardiac Pacemaker Market Value Share and Forecast, By Technology, 2023-2033
    8.2. Dual Chamber Pacemaker
    8.3. Single Chamber Pacemaker

    9. Global Leadless Cardiac Pacemaker Market, By Condition (USD Million)
    9.1. Global Leadless Cardiac Pacemaker Market Value Share and Forecast, By Condition, 2023-2033
    9.2. Atrial fibrillation
    9.3. Atrioventricular Block
    9.4. Sinus Node Dysfunction

    10. Global Leadless Cardiac Pacemaker Market, By End User (USD Million)
    10.1. Global Leadless Cardiac Pacemaker Market Value Share and Forecast, By End User, 2023-2033
    10.2. Academic & Research Institutes
    10.3. Ambulatory Surgical Centers
    10.4. Hospitals, 
    10.5. Others

    11. Global Leadless Cardiac Pacemaker Market Forecast, 2019-2033 (USD Million)
    11.1. Global Leadless Cardiac Pacemaker Market Size and Market Share

    12. Global Leadless Cardiac Pacemaker Market, By Type, 2019-2033 (USD Million)
    12.1. Global Leadless Cardiac Pacemaker Market Size and Market Share By Type (2019-2026)
    12.2. Global Leadless Cardiac Pacemaker Market Size and Market Share By Type (2027-2033)

    13. Global Leadless Cardiac Pacemaker Market, By Technology, 2019-2033 (USD Million)
    13.1. Global Leadless Cardiac Pacemaker Market Size and Market Share By Technology (2019-2026)
    13.2. Global Leadless Cardiac Pacemaker Market Size and Market Share By Technology (2027-2033)

    14. Global Leadless Cardiac Pacemaker Market, By Condition, 2019-2033 (USD Million)
    14.1. Global Leadless Cardiac Pacemaker Market Size and Market Share By Condition (2019-2026)
    14.2. Global Leadless Cardiac Pacemaker Market Size and Market Share By Condition (2027-2033)

    15. Global Leadless Cardiac Pacemaker Market, By End User, 2019-2033 (USD Million)
    15.1. Global Leadless Cardiac Pacemaker Market Size and Market Share By End User (2019-2026)
    15.2. Global Leadless Cardiac Pacemaker Market Size and Market Share By End User (2027-2033)

    16. Global Leadless Cardiac Pacemaker Market, By Region, 2019-2033 (USD Million)
    16.1. Global Leadless Cardiac Pacemaker Market Size and Market Share By Region (2019-2026)
    16.2. Global Leadless Cardiac Pacemaker Market Size and Market Share By Region (2027-2033)
    16.3. Asia-Pacific
    16.3.1. Australia
    16.3.2. China
    16.3.3. India
    16.3.4. Japan
    16.3.5. South Korea
    16.3.6. Rest of Asia-Pacific
    16.4. Europe
    16.4.1. France
    16.4.2. Germany
    16.4.3. Italy
    16.4.4. Spain
    16.4.5. United Kingdom
    16.4.6. Rest of Europe
    16.5. Middle East and Africa
    16.5.1. Kingdom of Saudi Arabia 
    16.5.2. United Arab Emirates
    16.5.3. Rest of Middle East & Africa
    16.6. North America
    16.6.1. Canada
    16.6.2. Mexico
    16.6.3. United States
    16.7. Latin America
    16.7.1. Argentina
    16.7.2. Brazil
    16.7.3. Rest of Latin America

    17. Company Profile
    17.1. Abbott Laboratories Inc.
    17.1.1. Company details
    17.1.2. Financial outlook
    17.1.3. Product summary 
    17.1.4. Recent developments
    17.2. BIOTRONIK SE & Co. KG
    17.2.1. Company details
    17.2.2. Financial outlook
    17.2.3. Product summary 
    17.2.4. Recent developments
    17.3. Boston Scientific Corporation
    17.3.1. Company details
    17.3.2. Financial outlook
    17.3.3. Product summary 
    17.3.4. Recent developments
    17.4. Edward Lifesciences Corporation
    17.4.1. Company details
    17.4.2. Financial outlook
    17.4.3. Product summary 
    17.4.4. Recent developments
    17.5. Lepu Medical Technology
    17.5.1. Company details
    17.5.2. Financial outlook
    17.5.3. Product summary 
    17.5.4. Recent developments
    17.6. MEDICO S.p.A.
    17.6.1. Company details
    17.6.2. Financial outlook
    17.6.3. Product summary 
    17.6.4. Recent developments
    17.7. Medtronic Plc
    17.7.1. Company details
    17.7.2. Financial outlook
    17.7.3. Product summary 
    17.7.4. Recent developments
    17.8. SORIN S.p.A
    17.8.1. Company details
    17.8.2. Financial outlook
    17.8.3. Product summary 
    17.8.4. Recent developments
    17.9. Terumo Corporation
    17.9.1. Company details
    17.9.2. Financial outlook
    17.9.3. Product summary 
    17.9.4. Recent developments
    17.10. Vitatron
    17.10.1. Company details
    17.10.2. Financial outlook
    17.10.3. Product summary 
    17.10.4. Recent developments
    17.11. Others

    18. List of Abbreviations

    19. Reference Links

    20. Conclusion

    21. Research Scope

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    Leadless Cardiac Pacemaker Market is projected to reach USD 0.60 billion by 2033, growing at a CAGR of 17.42% during the forecast period.
    Leadless Cardiac Pacemaker Market grew in market size from 2022. The Market is expected to reach USD 0.60 billion by 2033, at a CAGR of 17.42% during the forecast period.
    Leadless Cardiac Pacemaker Market CAGR of 17.42% during the forecast period.
    Leadless Cardiac Pacemaker Market size is USD 0.60 billion from 2023 to 2033.
    Leadless Cardiac Pacemaker Market Segment is covered By Type, By Technology, By Condition, By End User.
    The North America region is anticipated to have the highest market share in the Leadless Cardiac Pacemaker Market.
    The key players in the market include Companies Covered Abbott Laboratories Inc., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Edward Lifesciences Corporation, Lepu Medical Technology, MEDICO S.p.A., Medtronic Plc, SORIN S.p.A, Terumo Corporation, Vitatron, others.
    These elements help the market grow and adoption rates increase. Leadless cardiac pacemakers are anticipated to function better and have more features in the future thanks to technical developments and continuous R&D projects, which will boost the market's expansion.
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here
    PLACE AN ORDER
    • 15% off
       
      $ 4250
    • 20% off
               
      $ 5650
    • 25% off
           
      $ 7450
    Pre-Purchase Inquiry
    SEND AN INQUIRY
    NEED CUSTOMIZATION?
    Request Customization
    CALL OR EMAIL US
    US:
    India:
    Email:
    100% Secure Payment

    SPER American Express
    SPER VISA
    SPER Master Card
    SPER Mestro
    SPER Paypal
    SPER CCAvenues

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-McKinsey
    SPER-Bain
    SPER-Max-Healthcare
    SPER-DHL
    SPER-SIEMENS
    SPER-IQVIA
    SPER-Pfizer
    SPER-LOREAL
    SPER-Kankar IMRB
    SPER-ITA
    SPER-PWC
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-IPSOS
    SPER-Heineken

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650